Should clinicians consider rescanning 3 to 7 years after a coronary artery calcium (CAC) score of 0? In this interview, Renee Bullock-Palmer, MD; Omar Dzaye, MD, PhD; Michael Blaha, MD, MPH; and Yuvraj Chowdhury, MD, discuss a “warranty period” for CAC scoring. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

Current guidelines recommend measuring out-of-office BP to confirm office BP. The results of a study published in the JACC suggest that home BP measurement may be the best approach for out-of-office BP monitoring. In this interview, Alison Bailey, MD, FACC; Daichi Shimbo, MD; and Nosheen Reza, MD, discuss the reliability of office, home, and ambulatory BP measurements. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

Based on the SOLOIST-WHF and SCORED trials, there is now evidence to treat patients with HFpEF with SGLT2 inhibitors and to start treatment early in HFrEF and HFpEF. In this interview, L. Kristin Newby, MD, MHS, FACC; Deepak L. Bhatt MD, FACC; and Shashank Sinha, MD, discuss the expanding biology of SGLT2. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

Patients with cancer presenting with a heart attack are less likely to receive invasive treatment because of perceived risks and poor outcomes. In this interview, Mamas A. Mamas, MA, DPhil, BMBCh; Ana Barac, MD, PhD, FACC; and Sun Moon Kim, MD, discuss a current study showing that patients with cancer admitted with a heart attack receiving invasive treatment gain as much benefit as patients without cancer. For 20+ insider interviews like these every month with CME/MOC credit, subscribe at www.ACC.org/ACCEL.

Increased scientific data and various guidelines now support use of computed tomography coronary angiography (CTCA) in various clinical settings. However, a knowledge gap remains regarding its usefulness in patient care. In this interview, Ron Blankstein, MD; Allen J. Taylor MD, FACC; and Poonam Velagapudi MD, MS, discuss when noninvasive CTCA can be used instead of cardiac catheterization. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

Peripartum heart failure can be difficult to recognize because the symptoms may be similar to those of normal pregnancy; however, it’s important to make the diagnosis so that women can receive the correct medications and treatment. In this interview, Michelle Kittleson, MD, FACC; Melinda B. Davis, MD, FACC; and Jeffrey Hsu, MD, PhD, discuss how to recognize and treat peripartum heart failure.

Clinical studies have reported a prevalence of myocardial infarction with nonobstructive coronary arteries (MINOCA) of 5-6% of acute myocardial infarction cases, with a range of 5-15% depending on the population examined. In this interview, Deepak L. Bhatt, MPH, MD, FACC; Vijay Kunadian, MBBS, MD, FACC; and Michelle Kelsey, MD, discuss what MINOCA is and what to do about it.

In this interview, John McMurray, MD, and Alison Bailey, MD, with Nosheen Reza, MD, discuss the use of mineralocorticoid-receptor antagonist and outcomes in heart failure with reduced ejection fraction.

New analyses highlight the atrial fibrillation subpopulations with potential to progress to major morbidity outcomes and permit a reevaluation of the benefits of rhythm control for these endpoints and need for early restoration of rhythm control. In this interview, Sanjeev Saksena MBBS, MD, FACC, and Andrea M. Russo MD, FACC, with Arav Jhand, MD, discuss reinterpreting the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) study in 2020.

Given the low cost of coronary artery calcium (CAC) testing and the high likelihood that it will change management of the patient, the cost-effectiveness of CAC testing is robust due to better and more accurate targeting of intermediate risk patients to statin and aspirin therapy and promotion of adherence to those therapies. In this interview, Matthew Budoff, MD; C. Noel Bairey Merz, MD, FACC; and Poonam Velagapudi, MD, MS, discuss the cost-effectiveness of CAC testing and statin therapy.